ethyl [(3R,5R)-5-({4-[(3-chloro-4-{[(3-fluorophenyl) methyl] oxy} phenyl) amino] thieno[3,2-d]pyrimidin-6-yl} ethynyl)-3-pyrrolidinyl] carbamate | 833476-81-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并嘧啶酮衍生物
• 英文名称: ethyl [(3R,5R)-5-({4-[(3-chloro-4-{[(3-fluorophenyl) methyl] oxy} phenyl) amino] thieno[3,2-d]pyrimidin-6-yl} ethynyl)-3-pyrrolidinyl] carbamate
• 英文别名: (3R,5R)-5-({4-[(3-chloro-4-{[(3-fluorophenyl)methyl] oxy} phenyl) amino] thieno[3,2-d]pyrimidin-6-yl} ethynyl)-3-pyrrolidinyl ethylcarbamate；(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate；[(3R,5R)-5-[2-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-yl] N-ethylcarbamate
• CAS: 833476-81-6
• 化学式: C₂₈H₂₅ClFN₅O₃S
• 分子量: 566.056
• InChiKey: IYINYGZMZPUBOK-PZJWPPBQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  39
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  126
• 氢给体数：
  3
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 ethyl [(3R,5R)-5-({4-[(3-chloro-4-{[(3-fluorophenyl) methyl] oxy} phenyl) amino] thieno[3,2-d]pyrimidin-6-yl} ethynyl)-3-pyrrolidinyl] carbamate
  参考文献：
  名称：

  Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors

  摘要：

  A novel class of pyrrolidinyl-acetyleneic thieno[3,2-d]pyrimidines has been identified which potently inhibit the EGFR and ErbB-2 receptor tyrosine kinases. Synthetic modifications of the pyrrolidine carbamate moiety result in a range of effects on enzyme and cellular potency. In addition, the impact of the absolute stereochemical configuration on cellular potency and oral mouse pharmacokinetics is described. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.11.023

文献信息

• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2005007083A2

  公开（公告）日：2005-01-27

  The present invention discloses thienopyrimidine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such thienopyrimidine derivatives are useful in the treatment of diseases associated with inappropriate ErbB family kinase activity.